Development of KGF Antagonist as a Breast Cancer Therapeutic
Abstract
This grant proposal was to synthesize potential KGF antagonists which will then be evaluated for efficacy in vitro assay systems. The results generated for the propose study would be useful for designing new therapeutic agent for breast cancer. We were able to show some potential intracellular KGFR target small molecules whereas extracellular target synthetic peptide antagonist was not able to do during this period We also added a new dimension to an estrogen-KGF involved human breast microenvironment (i.e. KGF regulates estrogen receptor a mRNA and protein expression).
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2003
- Accession Number
- ADA421458
Entities
People
- Yasuro Sugimoto
Organizations
- Ohio State University